The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Annamaria Colao

Department of Molecular and Clinical Endocrinology and Oncology

Section of Endocrinology

Federico II University of Naples

Naples

Italy

[email]@unina.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Molecular and Clinical Endocrinology and Oncology, Section of Endocrinology, Federico II University of Naples, Naples, Italy. 1999 - 2011

References

  1. Improvement of cardiac parameters in patients with acromegaly treated with medical therapies. Colao, A. Pituitary (2011) [Pubmed]
  2. Resistance to somatostatin analogs in acromegaly. Colao, A., Auriemma, R.S., Lombardi, G., Pivonello, R. Endocr. Rev. (2011) [Pubmed]
  3. Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects. Colao, A., Pivonello, R., Auriemma, R.S., Grasso, L.F., Galdiero, M., Pivonello, C., Lombardi, G., Savastano, S. Clin. Endocrinol. (Oxf) (2011) [Pubmed]
  4. Prolactinomas in children and adolescents. Colao, A., Loche, S. Endocr. Dev (2010) [Pubmed]
  5. Pituitary carcinomas. Colao, A., Ochoa, A.S., Auriemma, R.S., Faggiano, A., Pivonello, R., Lombardi, G. Front. Horm. Res (2010) [Pubmed]
  6. Somatostatin analogues: treatment of pituitary and neuroendocrine tumors. Colao, A., Faggiano, A., Pivonello, R. Prog. Brain Res. (2010) [Pubmed]
  7. Dose optimization of somatostatin analogues for acromegaly patients. Colao, A., Lombardi, G. J. Endocrinol. Invest. (2010) [Pubmed]
  8. A reappraisal of diagnosing GH deficiency in adults: role of gender, age, waist circumference, and body mass index. Colao, A., Di Somma, C., Savastano, S., Rota, F., Savanelli, M.C., Aimaretti, G., Lombardi, G. J. Clin. Endocrinol. Metab. (2009) [Pubmed]
  9. Pituitary tumours: the prolactinoma. Colao, A. Best Pract. Res. Clin. Endocrinol. Metab. (2009) [Pubmed]
  10. Octreotide LAR vs. surgery in newly diagnosed patients with acromegaly: a randomized, open-label, multicentre study. Colao, A., Cappabianca, P., Caron, P., De Menis, E., Farrall, A.J., Gadelha, M.R., Hmissi, A., Rees, A., Reincke, M., Safari, M., T'Sjoen, G., Bouterfa, H., Cuneo, R.C. Clin. Endocrinol. (Oxf) (2009) [Pubmed]
  11. Effects of initial therapy for five years with somatostatin analogs for acromegaly on growth hormone and insulin-like growth factor-I levels, tumor shrinkage, and cardiovascular disease: a prospective study. Colao, A., Auriemma, R.S., Galdiero, M., Lombardi, G., Pivonello, R. J. Clin. Endocrinol. Metab. (2009) [Pubmed]
  12. Significant tumour shrinkage after 12 months of lanreotide Autogel-120 mg treatment given first-line in acromegaly. Colao, A., Auriemma, R.S., Rebora, A., Galdiero, M., Resmini, E., Minuto, F., Lombardi, G., Pivonello, R., Ferone, D. Clin. Endocrinol. (Oxf) (2009) [Pubmed]
  13. Medical therapy of pituitary adenomas: effects on tumor shrinkage. Colao, A., Pivonello, R., Di Somma, C., Savastano, S., Grasso, L.F., Lombardi, G. Rev. Endocr. Metab. Disord (2009) [Pubmed]
  14. Impact of somatostatin analogs versus surgery on glucose metabolism in acromegaly: results of a 5-year observational, open, prospective study. Colao, A., Auriemma, R.S., Galdiero, M., Cappabianca, P., Cavallo, L.M., Esposito, F., Grasso, L.F., Lombardi, G., Pivonello, R. J. Clin. Endocrinol. Metab. (2009) [Pubmed]
  15. Glucose tolerance and somatostatin analog treatment in acromegaly: a 12-month study. Colao, A., Auriemma, R.S., Savastano, S., Galdiero, M., Grasso, L.F., Lombardi, G., Pivonello, R. J. Clin. Endocrinol. Metab. (2009) [Pubmed]
  16. 5 Long-term acromegaly and associated cardiovascular complications: a case-based review. Colao, A. Best Pract. Res. Clin. Endocrinol. Metab. (2009) [Pubmed]
  17. Medical therapy for clinically non-functioning pituitary adenomas. Colao, A., Di Somma, C., Pivonello, R., Faggiano, A., Lombardi, G., Savastano, S. Endocr. Relat. Cancer (2008) [Pubmed]
  18. No greater incidence or worsening of cardiac valve regurgitation with somatostatin analog treatment of acromegaly. Colao, A., Marek, J., Goth, M.I., Caron, P., Kuhn, J.M., Minuto, F.M., Weissman, N.J. J. Clin. Endocrinol. Metab. (2008) [Pubmed]
  19. Impact of treating acromegaly first with surgery or somatostatin analogs on cardiomyopathy. Colao, A., Pivonello, R., Galderisi, M., Cappabianca, P., Auriemma, R.S., Galdiero, M., Cavallo, L.M., Esposito, F., Lombardi, G. J. Clin. Endocrinol. Metab. (2008) [Pubmed]
  20. Growth hormone treatment on atherosclerosis: results of a 5-year open, prospective, controlled study in male patients with severe growth hormone deficiency. Colao, A., Di Somma, C., Spiezia, S., Savastano, S., Rota, F., Savanelli, M.C., Lombardi, G. J. Clin. Endocrinol. Metab. (2008) [Pubmed]
  21. Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects. Colao, A., Di Somma, C., Cascella, T., Pivonello, R., Vitale, G., Grasso, L.F., Lombardi, G., Savastano, S. Eur. J. Endocrinol. (2008) [Pubmed]
  22. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment. Colao, A., Terzolo, M., Bondanelli, M., Galderisi, M., Vitale, G., Reimondo, G., Ambrosio, M.R., Pivonello, R., Lombardi, G., Angeli, A., degli Uberti, E.C. Clin. Endocrinol. (Oxf) (2008) [Pubmed]
  23. Growth hormone-secreting tumor shrinkage after 3 months of octreotide-long-acting release therapy predicts the response at 12 months. Colao, A., Pivonello, R., Auriemma, R.S., Galdiero, M., Savastano, S., Grasso, L.F., Lombardi, G. J. Clin. Endocrinol. Metab. (2008) [Pubmed]
  24. Increased prevalence of tricuspid regurgitation in patients with prolactinomas chronically treated with cabergoline. Colao, A., Galderisi, M., Di Sarno, A., Pardo, M., Gaccione, M., D'Andrea, M., Guerra, E., Pivonello, R., Lerro, G., Lombardi, G. J. Clin. Endocrinol. Metab. (2008) [Pubmed]
  25. The GH-IGF-I axis and the cardiovascular system: clinical implications. Colao, A. Clin. Endocrinol. (Oxf) (2008) [Pubmed]
  26. Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study. Colao, A., Abs, R., Bárcena, D.G., Chanson, P., Paulus, W., Kleinberg, D.L. Clin. Endocrinol. (Oxf) (2008) [Pubmed]
  27. Medical consequences of acromegaly: what are the effects of biochemical control?. Colao, A., Auriemma, R.S., Pivonello, R., Galdiero, M., Lombardi, G. Rev. Endocr. Metab. Disord (2008) [Pubmed]
  28. Beneficial effect of dose escalation of octreotide-LAR as first-line therapy in patients with acromegaly. Colao, A., Pivonello, R., Auriemma, R.S., Galdiero, M., Savastano, S., Lombardi, G. Eur. J. Endocrinol. (2007) [Pubmed]
  29. Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy. Colao, A., Di Sarno, A., Guerra, E., Pivonello, R., Cappabianca, P., Caranci, F., Elefante, A., Cavallo, L.M., Briganti, F., Cirillo, S., Lombardi, G. Clin. Endocrinol. (Oxf) (2007) [Pubmed]
  30. A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients. Colao, A., Pivonello, R., Spinelli, L., Galderisi, M., Auriemma, R.S., Galdiero, M., Vitale, G., De Leo, M., Lombardi, G. J. Endocrinol. Invest. (2007) [Pubmed]
  31. Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours. Colao, A., Filippella, M., Pivonello, R., Di Somma, C., Faggiano, A., Lombardi, G. Eur. J. Endocrinol. (2007) [Pubmed]
  32. The role of somatostatin and dopamine receptors as molecular targets for the treatment of patients with pituitary adenomas. Colao, A., Hofland, L.J. Eur. J. Endocrinol. (2007) [Pubmed]
  33. Growth hormone excess with onset in adolescence: clinical appearance and long-term treatment outcome. Colao, A., Pivonello, R., Di Somma, C., Tauchmanovà, L., Savastano, S., Lombardi, G. Clin. Endocrinol. (Oxf) (2007) [Pubmed]
  34. The importance of presurgical somatostatin analogue therapy in acromegaly. Colao, A. Endokrynol. Pol (2007) [Pubmed]
  35. The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients. Colao, A., Pivonello, R., Auriemma, R.S., Galdiero, M., Ferone, D., Minuto, F., Marzullo, P., Lombardi, G. J. Clin. Endocrinol. Metab. (2007) [Pubmed]
  36. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly. Colao, A., Attanasio, R., Pivonello, R., Cappabianca, P., Cavallo, L.M., Lasio, G., Lodrini, A., Lombardi, G., Cozzi, R. J. Clin. Endocrinol. Metab. (2006) [Pubmed]
  37. First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial. Colao, A., Pivonello, R., Rosato, F., Tita, P., De Menis, E., Barreca, A., Ferrara, R., Mainini, F., Arosio, M., Lombardi, G. Clin. Endocrinol. (Oxf) (2006) [Pubmed]
  38. Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance. Colao, A., Pivonello, R., Auriemma, R.S., De Martino, M.C., Bidlingmaier, M., Briganti, F., Tortora, F., Burman, P., Kourides, I.A., Strasburger, C.J., Lombardi, G. Eur. J. Endocrinol. (2006) [Pubmed]
  39. The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis. Colao, A., Di Somma, C., Spiezia, S., Rota, F., Pivonello, R., Savastano, S., Lombardi, G. J. Clin. Endocrinol. Metab. (2006) [Pubmed]
  40. Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients. Colao, A., Pivonello, R., Auriemma, R.S., Briganti, F., Galdiero, M., Tortora, F., Caranci, F., Cirillo, S., Lombardi, G. J. Clin. Endocrinol. Metab. (2006) [Pubmed]
  41. Beginning to end: cardiovascular implications of growth hormone (GH) deficiency and GH therapy. Colao, A., Di Somma, C., Savanelli, M.C., De Leo, M., Lombardi, G. Growth Horm. IGF Res. (2006) [Pubmed]
  42. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly. Colao, A., Pivonello, R., Cavallo, L.M., Gaccione, M., Auriemma, R.S., Esposito, F., Cappabianca, P., Lombardi, G. Clin. Endocrinol. (Oxf) (2006) [Pubmed]
  43. Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women. Colao, A., Di Sarno, A., Guerra, E., De Leo, M., Mentone, A., Lombardi, G. Nature Clinical Practice. Endocrinology & Metabolism (2006) [Pubmed]
  44. First-line therapy of acromegaly: a statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group. Colao, A., Martino, E., Cappabianca, P., Cozzi, R., Scanarini, M., Ghigo, E. J. Endocrinol. Invest. (2006) [Pubmed]
  45. Growth hormone/insulin-like growth factor-I system and connective tissues: basic aspects and clinical implications. Colao, A., Barkan, A.L., Scarpa, R. Rheum. Dis. Clin. North Am. (2005) [Pubmed]
  46. Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency. Colao, A., Di Somma, C., Rota, F., Pivonello, R., Savanelli, M.C., Spiezia, S., Lombardi, G. J. Clin. Endocrinol. Metab. (2005) [Pubmed]
  47. Common carotid intima-media thickness in growth hormone (GH)-deficient adolescents: a prospective study after GH withdrawal and restarting GH replacement. Colao, A., Di Somma, C., Rota, F., Di Maio, S., Salerno, M., Klain, A., Spiezia, S., Lombardi, G. J. Clin. Endocrinol. Metab. (2005) [Pubmed]
  48. Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency. Colao, A., Di Somma, C., Cuocolo, A., Spinelli, L., Acampa, W., Spiezia, S., Rota, F., Savanelli, M.C., Lombardi, G. J. Clin. Endocrinol. Metab. (2005) [Pubmed]
  49. Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age. Colao, A., Spiezia, S., Di Somma, C., Pivonello, R., Marzullo, P., Rota, F., Musella, T., Auriemma, R.S., De Martino, M.C., Lombardi, G. J. Endocrinol. Invest. (2005) [Pubmed]
  50. Severe systemic complications of acromegaly. Colao, A., Pivonello, R., Marzullo, P., Auriemma, R.S., De Martino, M.C., Ferone, D., Lombardi, G. J. Endocrinol. Invest. (2005) [Pubmed]
  51. Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly. Colao, A., Pivonello, R., Cappabianca, P., Briganti, F., Tortora, F., Auriemma, R.S., De Martino, M.C., Marzullo, P., Lombardi, G. Clin. Endocrinol. (Oxf) (2005) [Pubmed]
  52. The acromegalic arthropathy. Colao, A., Pivonello, R., Scarpa, R., Vallone, G., Ruosi, C., Lombardi, G. J. Endocrinol. Invest. (2005) [Pubmed]
  53. New perspectives in the medical treatment of acromegaly. Colao, A., Pivonello, R., Auriemma, R.S., Galdiero, M., Guerra, E., Milone, F., De Leo, M., Lombardi, G. J. Endocrinol. Invest. (2005) [Pubmed]
  54. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Colao, A., Ferone, D., Marzullo, P., Lombardi, G. Endocr. Rev. (2004) [Pubmed]
  55. Hypothalamic-pituitary-gonadal axis function after successful kidney transplantation in men and women. Tauchmanovà, L., Carrano, R., Sabbatini, M., De Rosa, M., Orio, F., Palomba, S., Cascella, T., Lombardi, G., Federico, S., Colao, A. Hum. Reprod. (2004) [Pubmed]
  56. Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. Colao, A., Vitale, G., Cappabianca, P., Briganti, F., Ciccarelli, A., De Rosa, M., Zarrilli, S., Lombardi, G. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  57. Prolactin and prostate hypertrophy: a pilot observational, prospective, case-control study in men with prolactinoma. Colao, A., Vitale, G., Di Sarno, A., Spiezia, S., Guerra, E., Ciccarelli, A., Lombardi, G. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  58. The heart: an end-organ of GH action. Colao, A., Vitale, G., Pivonello, R., Ciccarelli, A., Di Somma, C., Lombardi, G. Eur. J. Endocrinol. (2004) [Pubmed]
  59. Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency. Colao, A., Di Somma, C., Filippella, M., Rota, F., Pivonello, R., Orio, F., Vitale, G., Lombardi, G. Clin. Endocrinol. (Oxf) (2004) [Pubmed]
  60. Cardiovascular effects of growth hormone treatment: potential risks and benefits. Colao, A. Horm. Res. (2004) [Pubmed]
  61. The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: an observational, case-control study. Colao, A., Di Somma, C., Cuocolo, A., Filippella, M., Rota, F., Acampa, W., Savastano, S., Salvatore, M., Lombardi, G. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  62. Effect of growth hormone (GH) and/or testosterone replacement on the prostate in GH-deficient adult patients. Colao, A., Di Somma, C., Spiezia, S., Filippella, M., Pivonello, R., Lombardi, G. J. Clin. Endocrinol. Metab. (2003) [Pubmed]
  63. Reversal of acromegalic cardiomyopathy in young but not in middle-aged patients after 12 months of treatment with the depot long-acting somatostatin analogue octreotide. Colao, A., Marzullo, P., Cuocolo, A., Spinelli, L., Pivonello, R., Bonaduce, D., Salvatore, M., Lombardi, G. Clin. Endocrinol. (Oxf) (2003) [Pubmed]
  64. Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. Colao, A., Sarno, A.D., Cappabianca, P., Briganti, F., Pivonello, R., Somma, C.D., Faggiano, A., Biondi, B., Lombardi, G. Eur. J. Endocrinol. (2003) [Pubmed]
  65. Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas. Colao, A., Filippella, M., Di Somma, C., Manzi, S., Rota, F., Pivonello, R., Gaccione, M., De Rosa, M., Lombardi, G. Endocrine (2003) [Pubmed]
  66. Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. Colao, A., Di Sarno, A., Cappabianca, P., Di Somma, C., Pivonello, R., Lombardi, G. N. Engl. J. Med. (2003) [Pubmed]
  67. The treatment algorithm of acromegaly. Colao, A., Pivonello, R., Cappabianca, P., Vitale, G., Lombardi, G. J. Endocrinol. Invest. (2003) [Pubmed]
  68. The use of a GH receptor antagonist in patients with acromegaly resistant to somatostatin analogs. Colao, A., Pivonello, R., Cappabianca, P., Auriemma, R.S., De Martino, M.C., Ciccarelli, A., de Divitiis, E., Lombardi, G. J. Endocrinol. Invest. (2003) [Pubmed]
  69. Influence of growth hormone on cardiovascular health and disease. Colao, A., Di Somma, C., Vitale, G., Filippella, M., Lombardi, G. Treat. Endocrinol (2003) [Pubmed]
  70. Effect of a six-month treatment with lanreotide on cardiovascular risk factors and arterial intima-media thickness in patients with acromegaly. Colao, A., Marzullo, P., Lombardi, G. Eur. J. Endocrinol. (2002) [Pubmed]
  71. The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study. Colao, A., di Somma, C., Pivonello, R., Cuocolo, A., Spinelli, L., Bonaduce, D., Salvatore, M., Lombardi, G. J. Clin. Endocrinol. Metab. (2002) [Pubmed]
  72. Lymphocyte subset pattern in acromegaly. Colao, A., Ferone, D., Marzullo, P., Panza, N., Pivonello, R., Orio, F., Grande, G., Bevilacqua, N., Lombardi, G. J. Endocrinol. Invest. (2002) [Pubmed]
  73. Dopamine receptor agonists for treating prolactinomas. Colao, A., di Sarno, A., Pivonello, R., di Somma, C., Lombardi, G. Expert. Opin. Investig. Drugs (2002) [Pubmed]
  74. (99m)Technetium pentavalent dimercaptosuccinic acid scintigraphy in the follow-up of clinically nonfunctioning pituitary adenomas after radiotherapy. Colao, A., Ferone, D., Lombardi, G., Lastoria, S. Clin. Endocrinol. (Oxf) (2002) [Pubmed]
  75. Cardiovascular consequences of early-onset growth hormone excess. Colao, A., Spinelli, L., Cuocolo, A., Spiezia, S., Pivonello, R., di Somma, C., Bonaduce, D., Salvatore, M., Lombardi, G. J. Clin. Endocrinol. Metab. (2002) [Pubmed]
  76. Gender- and age-related differences in the endocrine parameters of acromegaly. Colao, A., Amato, G., Pedroncelli, A.M., Baldelli, R., Grottoli, S., Gasco, V., Petretta, M., Carella, C., Pagani, G., Tambura, G., Lombardi, G. J. Endocrinol. Invest. (2002) [Pubmed]
  77. The cardiovascular risk of GH-deficient adolescents. Colao, A., Di Somma, C., Salerno, M., Spinelli, L., Orio, F., Lombardi, G. J. Clin. Endocrinol. Metab. (2002) [Pubmed]
  78. Short-term suppression of GH and IGF-I levels improves gonadal function and sperm parameters in men with acromegaly. Colao, A., De Rosa, M., Pivonello, R., Balestrieri, A., Cappabianca, P., Di Sarno, A., Rochira, V., Carani, C., Lombardi, G. J. Clin. Endocrinol. Metab. (2002) [Pubmed]
  79. Growth hormone and the heart. Colao, A., Marzullo, P., Di Somma, C., Lombardi, G. Clin. Endocrinol. (Oxf) (2001) [Pubmed]
  80. Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly. Colao, A., Spiezia, S., Cerbone, G., Pivonello, R., Marzullo, P., Ferone, D., Di Somma, C., Assanti, A.P., Lombardi, G. Clin. Endocrinol. (Oxf) (2001) [Pubmed]
  81. Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency. Colao, A., di Somma, C., Cuocolo, A., Spinelli, L., Tedesco, N., Pivonello, R., Bonaduce, D., Salvatore, M., Lombardi, G. J. Clin. Endocrinol. Metab. (2001) [Pubmed]
  82. Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly. Colao, A., Ferone, D., Marzullo, P., Cappabianca, P., Cirillo, S., Boerlin, V., Lancranjan, I., Lombardi, G. J. Clin. Endocrinol. Metab. (2001) [Pubmed]
  83. Are patients with acromegaly at high risk for dysrhythmias?. Colao, A. Clin. Endocrinol. (Oxf) (2001) [Pubmed]
  84. Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy. Colao, A., Baldelli, R., Marzullo, P., Ferretti, E., Ferone, D., Gargiulo, P., Petretta, M., Tamburrano, G., Lombardi, G., Liuzzi, A. J. Clin. Endocrinol. Metab. (2000) [Pubmed]
  85. Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization. Colao, A., Di Somma, C., Loche, S., Di Sarno, A., Klain, M., Pivonello, R., Pietrosante, M., Salvatore, M., Lombardi, G. Clin. Endocrinol. (Oxf) (2000) [Pubmed]
  86. Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide. Colao, A., Ferone, D., Lastoria, S., Cerbone, G., Di Sarno, A., Di Somma, C., Lucci, R., Lombardi, G. Clin. Endocrinol. (Oxf) (2000) [Pubmed]
  87. Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients. Colao, A., Di Sarno, A., Landi, M.L., Scavuzzo, F., Cappabianca, P., Pivonello, R., Volpe, R., Di Salle, F., Cirillo, S., Annunziato, L., Lombardi, G. J. Clin. Endocrinol. Metab. (2000) [Pubmed]
  88. Effect of GH and/or testosterone deficiency on the prostate: an ultrasonographic and endocrine study in GH-deficient adult patients. Colao, A., Spiezia, S., Di Somma, C., Marzullo, P., Cerbone, G., Pivonello, R., Faggiano, A., Lombardi, G. Eur. J. Endocrinol. (2000) [Pubmed]
  89. Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease. Colao, A., Pivonello, R., Faggiano, A., Filippella, M., Ferone, D., Di Somma, C., Cerbone, G., Marzullo, P., Fenzi, G., Lombardi, G. Clin. Endocrinol. (Oxf) (2000) [Pubmed]
  90. New medical approaches in pituitary adenomas. Colao, A., Di Sarno, A., Marzullo, P., Di Somma, C., Cerbone, G., Landi, M.L., Faggiano, A., Merola, B., Lombardi, G. Horm. Res. (2000) [Pubmed]
  91. Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly. Colao, A., Marzullo, P., Ferone, D., Spinelli, L., Cuocolo, A., Bonaduce, D., Salvatore, M., Boerlin, V., Lancranjan, I., Lombardi, G. J. Clin. Endocrinol. Metab. (2000) [Pubmed]
  92. Effect of two years of growth hormone and insulin-like growth factor-I suppression on prostate diseases in acromegalic patients. Colao, A., Marzullo, P., Spiezia, S., Giaccio, A., Ferone, D., Cerbone, G., Di Sarno, A., Lombardi, G. J. Clin. Endocrinol. Metab. (2000) [Pubmed]
  93. Clinical implications of somatostatin-receptor scintigraphy in ophthalmic Graves' disease. Colao, A., Pivonello, R., Lastoria, S., Faggiano, A., Ferone, D., Lombardi, G., Fenzi, G. Eur. J. Endocrinol. (2000) [Pubmed]
  94. Cabergoline. Colao, A., Lombardi, G., Annunziato, L. Expert. Opin. Pharmacother (2000) [Pubmed]
  95. The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency. Colao, A., Cerbone, G., Pivonello, R., Aimaretti, G., Loche, S., Di Somma, C., Faggiano, A., Corneli, G., Ghigo, E., Lombardi, G. J. Clin. Endocrinol. Metab. (1999) [Pubmed]
  96. Impact of patient's age and disease duration on cardiac performance in acromegaly: a radionuclide angiography study. Colao, A., Cuocolo, A., Marzullo, P., Nicolai, E., Ferone, D., Della Morte, A.M., Petretta, M., Salvatore, M., Lombardi, G. J. Clin. Endocrinol. Metab. (1999) [Pubmed]
  97. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. Colao, A., Di Somma, C., Pivonello, R., Loche, S., Aimaretti, G., Cerbone, G., Faggiano, A., Corneli, G., Ghigo, E., Lombardi, G. J. Clin. Endocrinol. Metab. (1999) [Pubmed]
  98. Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects. Colao, A., Marzullo, P., Spiezia, S., Ferone, D., Giaccio, A., Cerbone, G., Pivonello, R., Di Somma, C., Lombardi, G. J. Clin. Endocrinol. Metab. (1999) [Pubmed]
  99. Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. Colao, A., Pivonello, R., Spiezia, S., Faggiano, A., Ferone, D., Filippella, M., Marzullo, P., Cerbone, G., Siciliani, M., Lombardi, G. J. Clin. Endocrinol. Metab. (1999) [Pubmed]
  100. Impaired cardiac performance in elderly patients with growth hormone deficiency. Colao, A., Cuocolo, A., Di Somma, C., Cerbone, G., Della Morte, A.M., Nicolai, E., Lucci, R., Salvatore, M., Lombardi, G. J. Clin. Endocrinol. Metab. (1999) [Pubmed]
  101. Ultrasonographic evidence of joint thickening reversibility in acromegalic patients treated with lanreotide for 12 months. Colao, A., Marzullo, P., Vallone, G., Giaccio, A., Ferone, D., Rossi, E., Scarpa, R., Smaltino, F., Lombardi, G. Clin. Endocrinol. (Oxf) (1999) [Pubmed]
 
WikiGenes - Universities